Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An observational, multi centre, Italian, retrospective, real World evidence cohort study describing one and two year Annualized Relapse Rate (ARR) and proportion of patients with No Evidene of Disease Activity (NEDA-3) in patients treated with Fingolimod

Trial Profile

An observational, multi centre, Italian, retrospective, real World evidence cohort study describing one and two year Annualized Relapse Rate (ARR) and proportion of patients with No Evidene of Disease Activity (NEDA-3) in patients treated with Fingolimod

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Nov 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fingolimod (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms GENIUS
  • Most Recent Events

    • 14 Nov 2018 Preliminary results (n=391) assessing Annualized Relapse rate (ARR) and the proportion of patients with No Evidence of Disease Activity (NEDA-3) after 1 and 2 years of treatment, presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
    • 24 May 2018 New trial record
    • 23 May 2018 Preliminary results (n=391) presented at the 23rd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top